1847 Holdings LLC Announces Pricing of $11.1 Million Public Offering
1847 Holdings LLC Announces Pricing of $11.1 Million Public Offering
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / 1847 Holdings LLC (NYSE American:EFSH) ("1847 Holdings" or the "Company"), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, announced today the pricing of its "reasonable best efforts" public offering of securities for gross proceeds of $11.1 million, prior to deducting placement agent fees and other offering expenses payable by the Company.
紐約,紐約州/ ACCESSWIRE / 2024年10月29日 / 1847控股有限責任公司(紐約證券交易所美國:EFSH)("1847控股"或"公司"),一家專門在中等市場企業中識別被忽視的、具有深度價值投資機會的控股公司,今日宣佈其"合理盡力"的公開發行證券定價,募集的總收益爲1110萬美元,扣除公司應付的放置代理費用和其他發行費用。
The public offering is comprised of 8,809,512 units, at a public offering price of $1.26 per unit. Each unit is comprised of (i) one (1) common share or a pre-funded warrant to purchase one (1) common share at an exercise price of $0.01 per share, (ii) a series A warrant to purchase one (1) common share at an exercise price of $1.90 per share and (iii) a series B warrant to purchase one (1) common share at an exercise price of $2.52 per share.The closing of the public offering is expected to occur on or about October 30, 2024, subject to the satisfaction of customary closing conditions.
本次公開發行包括8,809,512個單位,每單位公開發行價爲1.26美元。每個單位包括(i)一(1)股普通股或預先擔保的認股權證,在每股0.01美元的行使價處購買一(1)股普通股,(ii)一系列購買定價爲每股1.90美元的普通股的A級認股權證,以及(iii)一系列購買定價爲每股2.52美元的普通股的B級認股權證。公開發行的結束預計在2024年10月30日或前後進行,視乎符合慣例的閉市條件。
Spartan Capital Securities, LLC is acting as the sole placement agent in connection with the offering.
Spartan Capital Securities,LLC擔任本次發行的唯一放置代理。
The Securities and Exchange Commission ("SEC") declared effective a registration statement on Form S-1 relating to these securities on October 28, 2024. A final prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. The offering is being made only by means of a prospectus, copies of which may be obtained, when available, from: Spartan Capital Securities, LLC, 45 Broadway, New York, NY 10006, at (212) 293-0123.
證券交易委員會("SEC")於2024年10月28日宣佈生效一份關於這些證券的S-1表格的註冊聲明。一份關於並描述本次發行條款的最終招股說明書將提交給SEC,並可在SEC的網站http://www.sec.gov上獲取。本次發行僅通過招股書進行,副本可在以下地點獲取(如果有的話):紐約紐約市45 Broadway,Spartan Capital Securities,LLC,電話(212)293-0123。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Tonix Pharmaceuticals Holding Corp.*,是一家完全整合的生物製藥公司,致力於發展富有創新性的治療和預防潛在疾病的製劑。公司正在研發針對纖維肌痛患者的產品TNX-102 SL,已經完成了兩項具有統計學意義的3期研究。TNX-102 SL也正在被開發用於治療急性壓力反應以及類纖維肌痛的長期COVID。Tonix的神經系統藥物組合包括TNX-1300(可卡因酯酶),這是一種用於治療可卡因中毒、被授予「突破性療法」稱號的生物製品。Tonix的免疫學研發組合包括生物製品,用於治療器官移植排斥、自身免疫和癌症,包括TNX-1500,這是一種人源單克隆抗體,靶向CD40L(CD40L或CD154)用於預防異體移植器官排斥並用於治療自身免疫性疾病。Tonix在罕見疾病和傳染病領域的正在研發中的產品。商業子公司Tonix Medicines市場上銷售Zembrace SymTouch(舒馬曲坦注射液)3毫克和Tosymra(舒馬曲坦鼻噴劑)10毫克,用於成年急性偏頭疼的治療。
About 1847 Holdings
關於1847 Holdings
1847 Holdings LLC (NYSE American:EFSH), a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue, and Principal of Lazard Freres Strategic Realty Investors. 1847 Holdings' investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises or lower-middle market businesses with limited exit options despite the intrinsic value of their business. Given this dynamic, 1847 Holdings can consistently acquire businesses it views as "solid" for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems of those businesses in order to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at higher valuations than the purchase price and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to 1847 Holdings' ability to pay regular and special dividends to shareholders.
1847 Holdings LLC(紐約證券交易所American:EFSH),一家公開交易的多元化收購控股公司,由Ellery W. Roberts創立,他是Parallel Investment Partners、Saunders Karp & Megrue的前合夥人,以及Lazard Freres Strategic Realty Investors的負責人。 1847 Holdings的投資論點是,資本市場的低效性使得許多小型企業或中低市場企業的創始人和/或利益相關者儘管業務固有價值,但卻擁有有限的退出期權。鑑於這一現狀,1847 Holdings可以持續收購其認爲"穩健"的企業,且以合理的現金流倍數,然後投入資源加強這些企業的基礎設施和系統,以改善業務運營。這些改進可能會導致運營子公司以比購買價格更高的估值進行銷售或首次公開發行(IPO),或者作爲永久持有,爲1847 Holdings支付給股東定期和特別的分紅。
SOURCE: 1847 Holdings LLC
來源:1847控股有限責任公司
譯文內容由第三人軟體翻譯。